|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| A61K 31/7088 | (2006.01) | ||
| A61K 31/712 | (2006.01) | ||
| A61P 27/02 | (2006.01) |
| (11) | Patento numeris | 3516060 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17781030.6 |
| Europos patento paraiškos padavimo data | 2017-09-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-07-31 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-07-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2017/074133 |
| Data | 2017-09-22 |
| (87) | Numeris | WO 2018/055134 |
| Data | 2018-03-29 |
| (30) | Numeris | Data | Šalis |
| 201616202 | 2016-09-23 | GB |
| (72) |
VAN DIEPEN, Hester Catharina , NL
TURUNEN, Janne Juha , NL
CHAN, Hee Lam , NL
|
| (73) |
ProQR Therapeutics II B.V. ,
Zernikedreef 9, 2333 CK Leiden,
NL
|
| (54) | ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF EYE DISEASE |
| ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF EYE DISEASE |